STIMULUS FREQUENCY
The simplest mode of stimulation is the delivery of single stimuli (SS) with a duration of <0.2 msec and of >50 mA at a frequency of <0. l Hz. Transmission failure commences when approximately 70% of receptors are occupied with relaxant and will be complete when 90% are occupied. High-frequency stimulation, >35 Hz, leads to sustained contraction -tetanic stimulus. This is more sensitive than SS because contraction is not sustained in the presence of nondepolarizing relaxants -"tetanic fade." Train-of-four (TOF) stimulation, 3 stimulation at 2 Hz, for 2 s every 10-12 s, does not require pre-relaxant control values as the first twitch in each train serves as the control. This is one of the reasons why TOF has gained widespread acceptance as a clinical monitor and as an investigator's tool. The TOF count (counting the number of responses to TOF stimulation) correlates well with first twitch height. The ratio of the fourth to the first response -TOF ratio (TOFR) -is more sensitive than SS for determining residual block. Although TOFR is easy to determine with a transducer and recorder, clinical assessment of the degree of fade, manually or visually, is difficult if the TOFR is greater than 0.5. 4 Double burst stimulation (DBS), 5 two 50 Hz stimuli, of 60 msec duration, repeated every 750 msec, enables fade to be detected more easily. 6 Post-tetanic count (PTC) makes use of the phenomenon of post-tetanic facilitation to estimate the degree of intense block when responses to SS, TOF, DBS and tetanus are absent. The TOF stimulation is interrupted every 4 min by SS at I Hz for ! min and then tetanus at 50 Hz for 5 s is applied before recommencing SS. The time to return of the response to TOF can be anticipated from the number of post-tetanic twitches present. 7.s NERVE FOR STIMULATION Any accessible nerve may be stimulated in the assessment of neuromuscular blockade but stimulation of the ulnar, with measurement of the effect at the adductor pollicis, is the most popular. Muscles of the hypothenar eminence are slightly more resistant to nondepolarizing relaxants but not as resistant as the muscles innervated by the median or facial nerves. 9 it is difficult to measure respiratory muscle activity in clinical practice. Several studies have shown that the diaphragm is more resistant than the adductor pollicis to muscle relaxants. ~o. ~
EMG VS TWITCH
Measuring the force of contraction in response to nerve stimulation is similar to the electromyogram (EMG).t2 Small differences are probably the result of measurement from different muscles. Recently introduced EMG monitors are sensitive and robust and do not require the bulky equipment necessary to measure twitch.
R90 CORRELATIONS OF NEUROMUSCULAR BLOCK AND RESPIRATORY FUNCTION
Several studies have correlated clinical tests, respiratory measurement and neuromuscular stimulation (Table I) . 12.13 Most of the indices have returned to normal when TOFR is >0.7. However, such a small fade is diMcult to detect clinically so that residual weakness should be anticipated until it is possible to assess the patient's ability to breathe, cough and maintain a patent airway. The TOFR must exceed 0.9 before all clinical tests have returned to normal, ~2 which further indicates that the responses obtained should be recorded. The introduction of actracurium and vecuronium met the requirements of intermediate duration. In addition, they had the benefit of minimal or absent haemodynamic effects. There remained the need to replace the longacting agents, pancuronium and d-tubocurarine, with agents of a similar duration but devoid of cardiovascular effects. More important, there was an urgent need to produce a short-acting drug to replace succinylcholine.
New neuromuscular blocking drugs
Four new agents are currently undergoing clinical trials. Two of them, doxacurium and pipecuronium, are long-acting agents without cardiovascular actions. Mivacurium and ORG 9426 are shorter-acting agents but fall short of the very rapid onset and recovery seen with succinylcholine. Two of these agents are similar to atracurium in structure -benzylisoquinolines and two are aminocorticosteroids.
Benzylisoquinolines

Doxacurium
Doxacurium is the most potent neuromuscular blocking drug to undergo clinical trial. The ED9s is [25] [26] [27] [28] [29] [30] Ixg" kg-t. it has a very slow onset to maximum blockade at subparalysing doses (10-13 min). The duration of clinical anaesthesia following 2 x ED95 doses of 90-120 min is similar to pancuronium as is the recovery index (recovery time from 25 to 75% twitch activity) of 30-50 min. It is devoid of cardiovascular effects and releases histamine only at doses >4 x ED95.15 in children the onset of action is slightly more rapid than in adults and the CANADIAN JOURNAl. OF ANAESTHESIA 
Mivacurium
Mivacurium is less potent than doxacurium. The ED9s in adults 18 is 55-80 ixg.kg -~ and in children ~9 90-110 I~g.kg -t. Onset of action is similar to atracurium and vecuronium in subparalysing doses: 4-5 min. Its duration of action is about half that of atracurium and the recovery index (5-7 min) is the most rapid of all nondepolarizing relaxants. The shorter duration and more rapid recovery result from its metabolism by plasma cholinesterase and the rate of breakdown has been estimated at about 88% that of succinylcholine. At high doses, 2-3 x ED95, mivacurium releases histamine and this is probably the reason for its similar haemodynamic profile to atracurium. 2~ The rapid rate of recovery makes mivacurium very suitable for administration by continuous infusion. 2~
Aminosteroids
Pipecuronium
Pipecuronium is a potent (ED95 50/xg-kg-~ in adults, 40 I~g" kg-t in children) long-acting neuromuscular blocking drug devoid of cardiovascular effects with a similar pharmacodynamic profile to pancuronium. The onset of action is 3-4 min, the duration of 2 • ED95 doses is 70-90 min, and the recovery index is 25-40 rain. Recovery is more rapid in children. It has a similar pharmacokinetic profile to pancuronium (VDss -300 ml'kg -~, Cp 2.5 ml.kg-~.min -~ and h 13 140 min). Clearance is decreased in renal failure and is associated with a prolonged duration of action. 22-24
ORG 9426
ORG 9426 is the least potent of nondepolarizing relaxants (ED95 300 I~g'kg-I) but it has the most rapid onset of action (maximum effect of subparalysing doses) of 1.5-2 min. Recovery occurs at a similar rate to vecuronium with a recovery index of 8-12 min. The pharmacokinetic The pharmacodynamic profiles of the new agents are compared with those of atracurium, vecuronium and succinylcholine in Table I !. The goal of producing long-acting agents with minimal or no cardiovascular effects has been achieved with doxacurium and pipecurium. However, the appreciation that the more rapid recovery of neuromuscular activity with the intermediate agents is associated with less impaired postoperative function has decreased the use of the long-acting agents. Despite the effectiveness of mivacurium and ORG 9426 there is still a need for a short-acting succinylcholine replacement.
Reversal of neuromuscular blockade
Pharmacology
Reversal of nondepolarizing relaxants is achieved by increasing the concentration of acetylcholine at the receptor by the use of the anticholinesterases -edrophonium, neostigmine or pyridostigmine. The active surface of the acetyl-cholinesterase molecule consists of anionic and esteratic sites. Edrophoniun combines at the anionic site by electrostatic bonding and at the esteratic site by hydrogen bonding. These bonds can be easily broken. Neostigmine and pyridostigmine also bind at the anionic site by electrostatic attachments. Their ester group is hydrolyzed and the carbamyl group is transferred and chemically bonded at the esteratic site. The carbamyl group must be removed by hydrolysis before the enzyme can function again. The reversal agents are inactivated by this reaction.
The reversal agents have several other modes of action which include endplate depolarization, release of acetylcholine and repetitive firing. It is uncertain which is of greater importance in the reversal of neuromuscular blocking drugs.
Dose-reponse curves have demonstrated that neostigmine is 15-20 times as potent as edrophonium when antagonizing 90% blocks due to pancurronium, 27 atracurium or vecuronium. 28 Nondepolarizing relaxants can be antagonized with edrophonium, neostigmine or pyridostigmine. The most important difference among them is in the onset of action when given in equipotent doses at a time when spontaneous recovery is well established. Edrophonium is the quickest and pyridostigmine the slowest.
Factors affecting reversal
CHOICE OF RELAXANT Reversal of d-tubocurarine and pancuronium by neostigmine is similar but gallamine is reversed more slowly. 29 Atracurium and vecuronium have more rapid rates of spontaneous recovery so that the recovery after reversal appears to be enhanced as compared with pancuronium. 3~
EXTENT OF SPONTANEOUS RECOVERY
Trial and error have shown that neostigmine in doses of 2-3 mg (or equivalent doses for edrophonium and pyridostigmine) will reverse most neuromuscular blocks. However, the more intense the block, the longer the recovery will take. When recovery of SS is >20% or when TOF shows four visible twitches the block is easily reversed. More intense blocks may still be reversible with larger doses of reversal agents but total block may be irreversible. Intense blocks, >90% twitch depression, fewer than two twitches of TOF, are more easily reversed with neostigmine than with edrophonium. 3~'3z PHARMACOKINETIC FACTORS Anticholinesterases act by "accelerating spontaneous recovery." Thus, decreased plasma clearance of the 
Les rdponses provoqudes
Les rEponses musculaires ,~ la stimulation nerveuse, habituellement dans les muscles de la main en r6ponse ,~ la stimulation cubitale, peuvent 6tre 6valu6s soit visuellement, soit en enregistrant la force de la contracture musculaire ou par Electromyographie. 
Nouveaux bloqueurs neuromusculaires
Savarese, 14 en ! 981, a soumis, qu'en pratique clinique, il y avait un besoin de bloqueurs neuromusculaires avec trois profils diffErents. Quatre nouveaux agents sont actuellement soumis "~ des Epreuves cliniques. Deux de ceux-ci, le doxacurium et le pipEcuronium, sont des agents ~ Iongue durEe d'action sans effets cardio-vasculaires. Le mivacurium et i'ORG 9426 sont des agents h durEe d'action plus courte mais qui sont encore loin de la vitesse d'action et de rEcupEration de la succinylcholine. Deux de ces agents ont une structure similaire h celle de I'atricurium -benzylisoquinolines -et deux sont des amino-corticostEroides.
Les benzylisoquinolines
Le doxacurium
Le doxacurium est le plus puissant bloqueur neuromusculaire h subir des essais cliniques. Son ED95 est de l'ordre de 25 ~ 30 p,g.kg -I. Son temps d'atteinte de I'effet maximal, ~t des doses sous-paralysantes est tr~s long ( l0 13 minutes). La durEe de I'anesthEsie clinique consEcutive h une dose de 2 x ED95 est de I'ordre de 90 h 120 minutes, ce qui est semblable h la durEe du pancuronium, tout comme I'est I'index de r~cupEration (temps de rEcupEration de 25 ,a 75% du twitch) qui est aussi de I'ordre de 30 :~ 50 minutes. II n'a pas d'effet cardiovasculaire et rei~che l'histamine seulement h des doses plus grandes que 4 x ED95. ~5 Chez les enfants, le debut d'action est IEgErement plus rapide que chez l'adulte et la rEcupEration est aussi plus rapide : la durEe du bloc en clinique est rEduite de moitiE. 16 Le bloc neuromusculaire peut ~tre renversE avec la nEostigmine et ~ des niveaux de blocs moins intense, avec l'Edrophonium. 17
Le mivacurium
Le mivacurium est moins puissant que le doxacurium. La dose efficace ED95 chez l'adulte ts est 55 ~ 80 p~g" kg -t et chez I'enfant 19 de 90 h I l0 la,g. kg -I. Le debut d'action est semblable :~ celui de ratracurium et du vEcuronium en doses sous-paralysantes : quatre ~ cinq minutes. Sa durEe d'action est ~ peu prEs moitiE moindre de celle de l'atracurium et I'index de rEcupEration (cinq h sept minutes) est le plus rapide parmi les non-dEpolarisants. La courte durEe d'action et la rEcupEration plus rapide proviennent de son mEtabolisme par les cholinestErases plasmatiques et son taux de degradation est estimE "~ 88% de celui de la succinylcholine. A des doses ElevEes, 2-3 x ED95, le mivacurium lib~re de I'histamine et c'est probablement la raison de son profil similaire ~ celui de l'atracurium. 2~ Sa vitesse de rEcupEration rend le mivacu- 
AminostEro~des
Pipdcuronium
Le Les agents inhibiteurs des musculorelaxants ont d'autres modes d'action qui comprennent la dEpolarisation de la plaque motrice, la liberation d'acEtycholine et la dEpolarisation ~ rEpEtition. On est peu certain de leur importance dans le renversement des blocs neuromusculaires.
Les doses courbes-rEponses montrent que la nEostigmine est 15 ~ 20 fois plus puissante que i'Edrophonium pour antagoniser les blocs ~ 90% amenEs par le pancuronium, 27 l'atracurium ou le vEcuronium. 2s
Les non-dEpolarisants peuvent ~tre antagonisEs avec l'Edrophonium, la nEostigmine ou la pyridostigmine. La difference la plus importante entre eux se retrouve dans leur debut d'action, quand ils sont donnEs en doses Equivalentes au moment ott la rEcupEration spontanEe est bien Etablie. L'Edrophonium est le plus rapide et la pyridostigmine la plus lente.
Facteurs
CHOIX DU RELAXANT Le renversement de la d-tubocurarine et du pancuronium par la nEostigmine est semblable, mais celui de la gallamine est plus lent. 29 L'atracurium et le vEcuronium ont des vitesses de rEcupEration spontanEe plus rapides de telle sorte que la rEcupEration apr/~s le renversement semble accentuEe si on la compare /~ celle du pancuronium. 3~ AMPLITUDE DE LA RI~CUPI~RATION SPONTANI~E Des essais empiriques out montrE que la nEostigmine ~ des doses de 2 b. 3 mg (ou des doses Equivalentes d'Edrophonium ou de pyridostigmine) va renverser la plupart des blocs neuromusculaires. Cependant, plus le bloc est intense, plus le temps de rEcupEration va 6tre long. Lorsque la rEcupEration de la stimulation simple est supErieure ~t 20% ou Iorsque le train-de-4 montre quatre saccades visibles, le bloc sera facilement renversE. Les blocs plus intenses pourront encore ~tre reversibles avec des doses plus importantes mais un bloc total peut ne pas 6tre reversible. Des blocs intenses, par exemple avec plus de 90% de depression de la rEponse, ou encore avec presence de deux saccades au train-de-4, seront plus facilement renversEes avec la nEostigmine qu'avec rEdrophonium. 1,32 FACTEURS 
PHARMACOCINI~TIQUES
Les anticholinestErases agissent en accEIErant la rEcupEration spontanEe. Ainsi une clearance plasmatique diminuEe de relaxants dans des situations d'insuffisance rEnale ou hEpatique augmentera la demi-vie d'Elimination et retardera la rEcupEration spontanEe ; le renversement .semble aussi retardE dans ces situations. De la mEme maniEre, la diminution de la clearance des relaxants chez les personnes ~gEes pourra produire un dElai de renversement. 33 INTERACTIONS 
MI~DICAMENTEUSES
Les bloqueurs neuromusculaires peuvent ~tre potentialisEs par plusieurs substances, incluant les antibiotiques, les vapeurs anesthEsiques, les anesthEsiques locaux, et les bloqueurs des canaux calciques. L'administration d'antagonistes agira seulement sur ia partie du bloc produite par les relaxants, de telle sorte que la rEcupEration totale pourra 6tre compromise. Par exemple, on a pu dEmontrer que le renversement du vEcuronium et de I'atracurium est retardE pendant I'anesthEsie ~ I'enflurane. 34 Des Etudes contr61Ees ont montrE un affaiblissement du renversement de la d-tubocurarine et du pancuronium pendant l'acidose respiratoire et I'alcalose mEtabolique. 36'37 Ceci peut avoir EtE la cause de curarisation rEsistante :h la nEostigmine. L'hypokaliEmie, l'hypermagnEsEmie et l'hypocalcEmie pourront non seulement Etre associEs avec une augmentation de I'action des relaxants mais aussi ~ un retard dans le renversement.
Persistance de la paralysie postopdratoire
On a retrouvE des incidences ElevEes de blocs neuromusculaires chez les patients :h I'arrivEe en salle de rEveil apr~s I'anesthEsie :~ Copenhague au Danmark, 3s b. Melbourne en Australie, 39 ~ Link6ping en Suede, 4~ h MontrEal au Canada 41 et ~t New Haven, Etats-Unis. 37 11 est un peu surprenant de constater que cette incidence n'a pas change dans les dix derni~res annEes malgrE l'utilisation plus importante de monitorage de la relaxation neuromusculaire. Le seul point encourageant est que cette incidence semble r moins importante chez les patients qui re~joivent les relaxants h courte durge d'action -I'atracurium et le vEcuronium. 4t-43
Suggestions cliniques
L'utilisation sEcuritaire des musculorelaxants depend de l'ajustement precis des doses des relaxants et de leurs antagonismes ~ l'aide du monitorage neuromusculaire. Quelques suggestions h propos du choix des antagonistes sont illustrEes darts la Tableau !1I. Le monitoring cesse trop souvent h la fin de la chiruigie et les patients courent de plus grands risques :~ la saile de rEveil alors que le monitoring et le personnel peuvent &re insuffisants.
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